Conclusions
The race to find an effective cure for COVID-19 is on. Most of the
candidate drugs in various clinical trials are being re-purposed but
none has been approved as at date. It is pertinent for the bedside
physicians to understand the mechanisms of action of these agents and
their peculiar adverse effects so they are properly guided on the
risk/benefit of the drugs they choose in managing COVID-19 patients.